110 related articles for article (PubMed ID: 29141400)
1. Antifungal treatment with echinocandins: a 10-year clinical experience.
Poves-Alvarez R; Cano-Hernández B; Balbás-Alvarez S; Román-García P; Heredia-Rodríguez M; Gómez-Sánchez E; Gómez-Pesquera E; Lorenzo-López M; Martínez-Rafael B; Muñoz-Moreno MF; Eiros JM; Tamayo E
Rev Esp Quimioter; 2017 Dec; 30(6):413-421. PubMed ID: 29141400
[TBL] [Abstract][Full Text] [Related]
2. Impact of empirical treatment with antifungal agents on survival of patients with candidemia.
Poves-Alvarez R; Cano-Hernández B; Muñoz-Moreno MF; Balbás-Alvarez S; Román-García P; Gómez-Sánchez E; Martínez-Rafael B; Gómez-Pesquera E; Lorenzo-López M; Alvarez-Fuente E; de la Varga O; Flores M; Eiros JM; Tamayo E; Heredia-Rodríguez M
Rev Esp Quimioter; 2019 Feb; 32(1):6-14. PubMed ID: 30499639
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
[TBL] [Abstract][Full Text] [Related]
4. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort.
López-Cortés LE; Almirante B; Cuenca-Estrella M; Garnacho-Montero J; Padilla B; Puig-Asensio M; Ruiz-Camps I; Rodríguez-Baño J;
Clin Microbiol Infect; 2016 Aug; 22(8):733.e1-8. PubMed ID: 27189197
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
[TBL] [Abstract][Full Text] [Related]
6. Initial antifungal strategy does not correlate with mortality in patients with candidemia.
Murri R; Scoppettuolo G; Ventura G; Fabbiani M; Giovannenze F; Taccari F; Milozzi E; Posteraro B; Sanguinetti M; Cauda R; Fantoni M
Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):187-93. PubMed ID: 26634352
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
8. Attributable mortality of candidemia after introduction of echinocandins.
Cornely FB; Cornely OA; Salmanton-García J; Koehler FC; Koehler P; Seifert H; Wingen-Heimann S; Mellinghoff SC
Mycoses; 2020 Dec; 63(12):1373-1381. PubMed ID: 32885534
[TBL] [Abstract][Full Text] [Related]
9. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: A time-dependent analysis.
Lin KY; Chen PY; Chuang YC; Wang JT; Sun HY; Sheng WH; Chen YC; Chang SC
J Infect; 2018 Sep; 77(3):242-248. PubMed ID: 29932963
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study.
Bassetti M; Peghin M; Carnelutti A; Righi E; Merelli M; Ansaldi F; Trucchi C; Alicino C; Sartor A; Toniutto P; Wauters J; Laleman W; Tascini C; Menichetti F; Luzzati R; Brugnaro P; Mesini A; Raviolo S; De Rosa FG; Lagunes L; Rello J; Dimopoulos G; Colombo AL; Nucci M; Vena A; Bouza E; Muñoz P; Tumbarello M; Losito R; Martin-Loeches I; Viscoli C
Intensive Care Med; 2017 Apr; 43(4):509-518. PubMed ID: 28271321
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period.
Colombo AL; Guimarães T; Sukienik T; Pasqualotto AC; Andreotti R; Queiroz-Telles F; Nouér SA; Nucci M
Intensive Care Med; 2014 Oct; 40(10):1489-98. PubMed ID: 25082359
[TBL] [Abstract][Full Text] [Related]
13. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010.
Chen PY; Chuang YC; Wang JT; Sheng WH; Yu CJ; Chu CC; Hsueh PR; Chang SC; Chen YC
J Microbiol Immunol Infect; 2014 Apr; 47(2):95-103. PubMed ID: 23063082
[TBL] [Abstract][Full Text] [Related]
14. Treatment of candidemia with echinocandins: data on hospital resource use from a real world setting.
Wade RL; Chaudhari P; Campbell RS; Hays HD; Nathanson BH; Yi J; Horn D
J Med Econ; 2012; 15(6):1130-8. PubMed ID: 22788668
[TBL] [Abstract][Full Text] [Related]
15. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
16. Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot study.
Micek ST; Arnold H; Juang P; Hampton N; McKenzie M; Scolarici M; Kollef M
Clin Ther; 2014 Sep; 36(9):1226-32. PubMed ID: 25064625
[TBL] [Abstract][Full Text] [Related]
17. Attributable mortality of candidemia at a German tertiary hospital from 1997 to 2001 before the introduction of echinocandins.
Blankenheim Y; Salmanton-García J; Seifert H; Cornely OA; Koehler P
Mycoses; 2022 Feb; 65(2):211-221. PubMed ID: 34847247
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.
Li Y; Du M; Chen LA; Liu Y; Liang Z
Mycopathologia; 2016 Aug; 181(7-8):485-95. PubMed ID: 26994763
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough candidemia in children: clinical and microbiological characteristics, therapeutic strategies and impact on outcomes.
Lai MY; Hsu JF; Chu SM; Wu IH; Huang HR; Lin CC; Lee IT; Chiang MC; Fu RH; Tsai MH
Future Microbiol; 2017 Jun; 12():695-705. PubMed ID: 28326813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
